BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 23500492)

  • 1. Conservation and variability in the structure and function of the Cas5d endoribonuclease in the CRISPR-mediated microbial immune system.
    Koo Y; Ka D; Kim EJ; Suh N; Bae E
    J Mol Biol; 2013 Oct; 425(20):3799-810. PubMed ID: 23500492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting it close: CRISPR-associated endoribonuclease structure and function.
    Hochstrasser ML; Doudna JA
    Trends Biochem Sci; 2015 Jan; 40(1):58-66. PubMed ID: 25468820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the Cmr2-Cmr3 subcomplex in the CRISPR-Cas RNA silencing effector complex.
    Osawa T; Inanaga H; Numata T
    J Mol Biol; 2013 Oct; 425(20):3811-23. PubMed ID: 23583914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analyses of the CRISPR protein Csc2 reveal the RNA-binding interface of the type I-D Cas7 family.
    Hrle A; Maier LK; Sharma K; Ebert J; Basquin C; Urlaub H; Marchfelder A; Conti E
    RNA Biol; 2014; 11(8):1072-82. PubMed ID: 25483036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cas5d protein processes pre-crRNA and assembles into a cascade-like interference complex in subtype I-C/Dvulg CRISPR-Cas system.
    Nam KH; Haitjema C; Liu X; Ding F; Wang H; DeLisa MP; Ke A
    Structure; 2012 Sep; 20(9):1574-84. PubMed ID: 22841292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cas5d processes pre-crRNA and is a member of a larger family of CRISPR RNA endonucleases.
    Garside EL; Schellenberg MJ; Gesner EM; Bonanno JB; Sauder JM; Burley SK; Almo SC; Mehta G; MacMillan AM
    RNA; 2012 Nov; 18(11):2020-8. PubMed ID: 23006625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
    Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
    Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
    Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the Csm3-Csm4 subcomplex in the type III-A CRISPR-Cas interference complex.
    Numata T; Inanaga H; Sato C; Osawa T
    J Mol Biol; 2015 Jan; 427(2):259-73. PubMed ID: 25451598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6.
    Niewoehner O; Jinek M
    RNA; 2016 Mar; 22(3):318-29. PubMed ID: 26763118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress of genome engineering technology via clustered regularly interspaced short palindromic repeats--a review].
    Li H; Qiu S; Song H
    Wei Sheng Wu Xue Bao; 2013 Oct; 53(10):1025-30. PubMed ID: 24409757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to study CRISPR RNA biogenesis and the key players involved.
    Behler J; Hess WR
    Methods; 2020 Feb; 172():12-26. PubMed ID: 31325492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamic simulations of protein/RNA complexes: CRISPR/Csy4 endoribonuclease.
    Estarellas C; Otyepka M; Koča J; Banáš P; Krepl M; Šponer J
    Biochim Biophys Acta; 2015 May; 1850(5):1072-1090. PubMed ID: 25450173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, structural, and biochemical characterization of a group of large Csn2 proteins involved in CRISPR-mediated bacterial immunity.
    Lee KH; Lee SG; Eun Lee K; Jeon H; Robinson H; Oh BH
    Proteins; 2012 Nov; 80(11):2573-82. PubMed ID: 22753072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional characterization of Streptococcus pyogenes Cas2 protein under different pH conditions.
    Ka D; Kim D; Baek G; Bae E
    Biochem Biophys Res Commun; 2014 Aug; 451(1):152-7. PubMed ID: 25079131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure and nucleic acid-binding activity of the CRISPR-associated protein Csx1 of Pyrococcus furiosus.
    Kim YK; Kim YG; Oh BH
    Proteins; 2013 Feb; 81(2):261-70. PubMed ID: 22987782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease.
    Sheppard NF; Glover CV; Terns RM; Terns MP
    RNA; 2016 Feb; 22(2):216-24. PubMed ID: 26647461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clustered regularly interspaced short palindromic repeats (CRISPRs): the hallmark of an ingenious antiviral defense mechanism in prokaryotes.
    Al-Attar S; Westra ER; van der Oost J; Brouns SJ
    Biol Chem; 2011 Apr; 392(4):277-89. PubMed ID: 21294681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR RNA and anti-CRISPR protein binding to the
    Hong S; Ka D; Yoon SJ; Suh N; Jeong M; Suh JY; Bae E
    J Biol Chem; 2018 Feb; 293(8):2744-2754. PubMed ID: 29348170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
    Chylinski K; Le Rhun A; Charpentier E
    RNA Biol; 2013 May; 10(5):726-37. PubMed ID: 23563642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.